Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (57)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Amack, J. D.
Right arrow Articles by Mahadevan, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amack, J. D.
Right arrow Articles by Mahadevan, M. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 8, 1975-1984, Copyright © 1999 by Oxford University Press

ARTICLES

Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model

JD Amack, AP Paguio and MS Mahadevan
Laboratory of Genetics and.

The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3'-untranslated region (3'-UTR) of the DM protein kinase gene ( DMPK ), but the mechanism(s) of pathogenesis remain unknown. Studies using DM patient materials have often produced confusing results. Therefore, to study the effects of the DM mutation in a controlled environment, we have established a cell culture model system using C2C12 mouse myoblasts. By expressing chimeric reporter constructs containing a reporter gene fused to a human DMPK 3'-UTR, we identified both cis and trans effects that are mediated by the DM mutation. Our data show that a mutant DMPK 3'-UTR, with as few as 57 CTGs, had a negative cis effect on protein expression and resulted in the aggregation of reporter transcripts into discrete nuclear foci. We determined by deletion analysis that an expanded (CTG) (n) tract alone was sufficient to mediate these cis effects. Furthermore, in contrast to the normal DMPK 3'-UTR mRNA, a mutant DMPK 3'-UTR mRNA with (CUG)(200)selectively inhibited myogenic differentiation of C2C12 myoblasts. Genetic analysis and the Cre- loxP system were used to clearly demonstrate that the myoblast fusion defect could be rescued by eliminating the expression of the mutant DMPK 3'-UTR transcript. Characterization of spontaneous deletion events mapped the inhibitory effect to the (CTG) (n) expansion and/or the 3' end of the DMPK 3'-UTR. These results provide evidence that the DM mutation acts in cis to reduce protein production (consistent with DMPK haploinsufficiency) and in trans as a 'riboregulator' to inhibit myogenesis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
L. Zhang, J. E. Lee, J. Wilusz, and C. J. Wilusz
The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells: IMPLICATIONS FOR MYOTONIC DYSTROPHY
J. Biol. Chem., August 15, 2008; 283(33): 22457 - 22463.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. J. Osborne and C. A. Thornton
RNA-dominant diseases
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R162 - R169.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. M. Houseley, Z. Wang, G. J. R. Brock, J. Soloway, R. Artero, M. Perez-Alonso, K. M. C. O'Dell, and D. G. Monckton
Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila
Hum. Mol. Genet., March 15, 2005; 14(6): 873 - 883.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. A. Timchenko, R. Patel, P. Iakova, Z.-J. Cai, L. Quan, and L. T. Timchenko
Overexpression of CUG Triplet Repeat-binding Protein, CUGBP1, in Mice Inhibits Myogenesis
J. Biol. Chem., March 26, 2004; 279(13): 13129 - 13139.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. J. Storbeck, S. Drmanic, K. Daniel, J. D. Waring, F. R. Jirik, D. J. Parry, N. Ahmed, L. A. Sabourin, J.-E Ikeda, and R. G. Korneluk
Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR
Hum. Mol. Genet., March 15, 2004; 13(6): 589 - 600.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y. Kino, D. Mori, Y. Oma, Y. Takeshita, N. Sasagawa, and S. Ishiura
Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats
Hum. Mol. Genet., March 1, 2004; 13(5): 495 - 507.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
P. E. Schulz, A. D. McIntosh, M. R. Kasten, B. Wieringa, and H. F. Epstein
A Role for Myotonic Dystrophy Protein Kinase in Synaptic Plasticity
J Neurophysiol, March 1, 2003; 89(3): 1177 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. D. Amack, S. R. Reagan, and M. S. Mahadevan
Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD
J. Cell Biol., November 7, 2002; 159(3): 419 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Seznec, O. Agbulut, N. Sergeant, C. Savouret, A. Ghestem, N. Tabti, J.-C. Willer, L. Ourth, C. Duros, E. Brisson, et al.
Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities
Hum. Mol. Genet., November 1, 2001; 10(23): 2717 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. A. Timchenko, P. Iakova, Z.-J. Cai, J. R. Smith, and L. T. Timchenko
Molecular Basis for Impaired Muscle Differentiation in Myotonic Dystrophy
Mol. Cell. Biol., October 15, 2001; 21(20): 6927 - 6938.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. D. Amack and M. S. Mahadevan
The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation
Hum. Mol. Genet., September 1, 2001; 10(18): 1879 - 1887.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. Furling, L. Coiffier, V. Mouly, J.P. Barbet, J. Lacau St Guily, K. Taneja, G. Gourdon, C. Junien, and G.S. Butler-Browne
Defective satellite cells in congenital myotonic dystrophy
Hum. Mol. Genet., September 1, 2001; 10(19): 2079 - 2087.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Mankodi, C. R. Urbinati, Q.-P. Yuan, R. T Moxley, V. Sansone, M. Krym, D. Henderson, M. Schalling, M. S. Swanson, and C. A. Thornton
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2
Hum. Mol. Genet., September 1, 2001; 10(19): 2165 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Khajavi, A. M. Tari, N. B. Patel, K. Tsuji, D. R. Siwak, M. L. Meistrich, N. H. A. Terry, and T. Ashizawa
'Mitotic drive' of expanded CTG repeats in myotonic dystrophy type 1 (DM1)
Hum. Mol. Genet., April 1, 2001; 10(8): 855 - 863.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. Mankodi, E. Logigian, L. Callahan, C. McClain, R. White, D. Henderson, M. Krym, and C. A. Thornton
Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Science, September 8, 2000; 289(5485): 1769 - 1772.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
C. J. Cummings and H. Y. Zoghbi
Fourteen and counting: unraveling trinucleotide repeat diseases
Hum. Mol. Genet., April 1, 2000; 9(6): 909 - 916.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. J. Good, Q. Chen, S. J. Warner, and D. C. Herring
A Family of Human RNA-binding Proteins Related to the Drosophila Bruno Translational Regulator
J. Biol. Chem., September 8, 2000; 275(37): 28583 - 28592.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.